Treatment of virus infections
AssigneeTx Medic AB
InventorLars BRUCE
Life of this patent
Estimating the term…
Abstract
The invention relates to dextran sulfate, or a pharmaceutically acceptable salt thereof, for use in prevention, inhibition and/or treatment of a flavivirus infection or infectious disease. The dextran sulfate, or the pharmaceutically acceptable salt thereof, has an average molecular weight equal to or below 10000 Da and an average sulfur content of equal to or above 15%.
Claims27
-18. (canceled)
A method for preventing, inhibiting or treating a flavivirus infection or infectious disease, the method comprises administering an effective amount of dextran sulfate, or a pharmaceutically acceptable salt thereof, having an average molecular weight equal to or below 10 000 Da and an average sulfur content of equal to or above 15% to a subject suffering from the flavivirus infection or infectious disease or having a risk of suffering from the flavivirus infection or infectious disease.
The method according to claim to 32, wherein the average molecular weight is within a range of from 4 500 to 7 500 Da.
Dependencies are inferred from the claim text.